Literature DB >> 3353622

Prognostic factors for local recurrence and survival in patients with localized extremity soft-tissue sarcoma.

C F Collin1, C Friedrich, J Godbold, S Hajdu, M F Brennan.   

Abstract

The charts of 423 patients with localized extremity soft-tissue sarcoma treated at our institution over a 10-year period (1968-1978) were reviewed. Data were subjected to both univariate and multivariate analysis, with independent variables in the multivariate analysis appearing in capital letters. Factors associated with an increased risk of local recurrence included the following: AGE greater than 53; PRESENTATION WITH RECURRENT DISEASE; HIGH TUMOR GRADE; positive regional nodes; TREATMENT BY LIMB-SPARING SURGERY (LSS); invasion of vital structures (LSS only); INADEQUATE MARGINS; and biopsy with delayed definitive resection. Survival was adversely affected by the following: AGE greater than 53; PAINFUL MASS; PROXIMAL SITE; SIZE greater than or equal to 10 cm; HIGH TUMOR GRADE; POSITIVE NODES; invasion of vital structures; TREATMENT BY AMPUTATION; INADEQUATE MARGINS; and local recurrence after treatment at our institution. Significant variations in both local recurrence and survival according to histopathology were also observed, with EMBRYONAL RHABDOMYOSARCOMA, ANGIOSARCOMA, and MALIGNANT PERIPHERAL NERVE TUMORS emerging as independent predictors of local recurrence. Using the Cox models for local recurrence and survival, patients were stratified into high-, intermediate-, and low-risk categories based on the presence or absence of each variable. Risk factor analysis should be part of the overall evaluation of each patient with extremity sarcoma.

Entities:  

Mesh:

Year:  1988        PMID: 3353622     DOI: 10.1002/ssu.2980040108

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  15 in total

1.  Multifactorial analysis of survival in primary extremity liposarcoma.

Authors:  H R Chang; J Gaynor; C Tan; S I Hajdu; M F Brennan
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

2.  Synovial sarcoma: a clinicopathological review.

Authors:  S A Henderson; R Davis; J R Nixon
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

3.  In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080.

Authors:  M Waheed Roomi; Vadim Ivanov; Tatiana Kalinovsky; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

4.  Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma.

Authors:  S Singer; J M Corson; R Gonin; B Labow; T J Eberlein
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

5.  Primary adult soft tissue sarcomas: analysis of 294 patients.

Authors:  Necati Alkis; Sadık Muallaoğlu; Murat Koçer; ülkü Yalçıntaş Arslan; Ayşe Gök Durnalı; Saadet Tokluoğlu; Gökhan Çelenkoğlu; Fatma Paksoy; Ugur Coskun
Journal:  Med Oncol       Date:  2010-02-24       Impact factor: 3.064

6.  A probabilistic analysis of completely excised high-grade soft tissue sarcomas of the extremity: an application of a Bayesian belief network.

Authors:  Jonathan Agner Forsberg; John H Healey; Murray F Brennan
Journal:  Ann Surg Oncol       Date:  2012-04-20       Impact factor: 5.344

7.  Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity.

Authors:  W C Williard; S I Hajdu; E S Casper; M F Brennan
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

8.  Multimodality therapy for metastatic sarcomas confined to the lung.

Authors:  Russell P Gollard; J Francis Turner
Journal:  Oncol Lett       Date:  2012-07-24       Impact factor: 2.967

9.  The role of multimodality therapy in soft-tissue sarcoma.

Authors:  M F Brennan; E S Casper; L B Harrison; M H Shiu; J Gaynor; S I Hajdu
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

10.  Prognostic factors and expression of MDM2 in patients with primary extremity liposarcoma.

Authors:  Rosalvo Zósimo Bispo Júnior; Olavo Pires de Camargo; Cláudia Regina G C M de Oliveira; Renée Zon Filippi; André Mathias Baptista; Marcelo Tadeu Caiero
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.